Compile Data Set for Download or QSAR
Report error Found 212 Enz. Inhib. hit(s) with Target = 'Peptidoglycan D,D-transpeptidase FtsI'
TargetPeptidoglycan D,D-transpeptidase FtsI(Pseudomonas aeruginosa)
Johnson & Johnson Pharmaceutical Research and Development

Curated by ChEMBL
LigandPNGBDBM50240480(CHEMBL158 | (2S,3S)-3-({(2Z)-2-(2-ammonio-1,3-thia...)
Affinity DataIC50: 68.9nMAssay Description:Inhibition of bocillin FL binding to Pseudomonas aeruginosa PAO1 penicillin-binding protein 3More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/26/2020
Entry Details Article
PubMed
TargetPeptidoglycan D,D-transpeptidase FtsI(Pseudomonas aeruginosa)
University of Oxford

LigandPNGBDBM50240426(CHEMBL702 | (2S,5R,6R)-6-{[(2R)-2-{[(4-ethyl-2,3-d...)
Affinity DataIC50: 166nMpH: 7.2 T: 2°CAssay Description:An appropriate amount of enzyme (4uM) was pre-incubated with the (5R)- or 5(S)-penicilloic acid in the assay buffer (50mM HEPES-NaOH buffer (pH 7.2) ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/20/2014
Entry Details Article
PubMed
TargetPeptidoglycan D,D-transpeptidase FtsI(Pseudomonas aeruginosa)
Johnson & Johnson Pharmaceutical Research and Development

Curated by ChEMBL
LigandPNGBDBM50420259(CEFTAZIDIME)
Affinity DataIC50: 182nMAssay Description:Inhibition of bocillin FL binding to Pseudomonas aeruginosa PAO1 penicillin-binding protein 3More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/26/2020
Entry Details Article
PubMed
TargetPeptidoglycan D,D-transpeptidase FtsI(Pseudomonas aeruginosa)
Johnson & Johnson Pharmaceutical Research and Development

Curated by ChEMBL
LigandPNGBDBM50378857(Zeftera | Zevtera | CEFTOBIPROLE)
Affinity DataIC50: 187nMAssay Description:Inhibition of bocillin FL binding to Pseudomonas aeruginosa PAO1 penicillin-binding protein 3More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/26/2020
Entry Details Article
PubMed
TargetPeptidoglycan D,D-transpeptidase FtsI(Pseudomonas aeruginosa)
Johnson & Johnson Pharmaceutical Research and Development

Curated by ChEMBL
LigandPNGBDBM50350470(Maxipime | CEFEPIME)
Affinity DataIC50: 208nMAssay Description:Inhibition of bocillin FL binding to Pseudomonas aeruginosa PAO1 penicillin-binding protein 3More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/26/2020
Entry Details Article
PubMed
TargetPeptidoglycan D,D-transpeptidase FtsI(Pseudomonas aeruginosa)
Johnson & Johnson Pharmaceutical Research and Development

Curated by ChEMBL
LigandPNGBDBM50213266(CHEBI:471744 | Imipenem | MK-0787)
Affinity DataIC50: 334nMAssay Description:Inhibition of bocillin FL binding to Pseudomonas aeruginosa PAO1 penicillin-binding protein 3More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/26/2020
Entry Details Article
PubMed
TargetPeptidoglycan D,D-transpeptidase FtsI(Pseudomonas aeruginosa)
Johnson & Johnson Pharmaceutical Research and Development

Curated by ChEMBL
LigandPNGBDBM50538667(CHEMBL4634190)
Affinity DataIC50: 2.50E+3nMAssay Description:Inhibition of Pseudomonas aeruginosa PBP3 assessed as reduction in fluorescence intensity of bocillin labeled protein pre-incubated for 20 mins befor...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/12/2021
Entry Details Article
PubMed
TargetPeptidoglycan D,D-transpeptidase FtsI(Pseudomonas aeruginosa)
Johnson & Johnson Pharmaceutical Research and Development

Curated by ChEMBL
LigandPNGBDBM50538667(CHEMBL4634190)
Affinity DataIC50: 2.50E+3nMAssay Description:Inhibition of Pseudomonas aeruginosa PBP3 assessed as reduction in fluorescence intensity using Bocillin-protein as fluorescent substrate preincubate...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/24/2022
Entry Details Article
PubMed
TargetPeptidoglycan D,D-transpeptidase FtsI(Pseudomonas aeruginosa)
Johnson & Johnson Pharmaceutical Research and Development

Curated by ChEMBL
LigandPNGBDBM50578473(CHEMBL4872152)
Affinity DataIC50: 5.00E+3nMAssay Description:Inhibition of Pseudomonas aeruginosa PBP3 assessed as reduction in fluorescence intensity using Bocillin-protein as fluorescent substrate preincubate...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/24/2022
Entry Details Article
PubMed
TargetPeptidoglycan D,D-transpeptidase FtsI()
Venatorx Pharmaceuticals

US Patent
LigandPNGBDBM708217(US12173018, Example 145)
Affinity DataEC50: <3.00E+4nMAssay Description:To establish assay conditions for competition binding, an enzyme titration/saturation binding experiment was initially performed. Bocillin-FL was pre...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
5/5/2025
Entry Details
Go to US Patent

TargetPeptidoglycan D,D-transpeptidase FtsI()
Venatorx Pharmaceuticals

US Patent
LigandPNGBDBM708215(US12173018, Example 143)
Affinity DataEC50: <3.00E+4nMAssay Description:To establish assay conditions for competition binding, an enzyme titration/saturation binding experiment was initially performed. Bocillin-FL was pre...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
5/5/2025
Entry Details
Go to US Patent

TargetPeptidoglycan D,D-transpeptidase FtsI()
Venatorx Pharmaceuticals

US Patent
LigandPNGBDBM708228(US12173018, Example 156)
Affinity DataEC50: <3.00E+4nMAssay Description:To establish assay conditions for competition binding, an enzyme titration/saturation binding experiment was initially performed. Bocillin-FL was pre...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
5/5/2025
Entry Details
Go to US Patent

TargetPeptidoglycan D,D-transpeptidase FtsI()
Venatorx Pharmaceuticals

US Patent
LigandPNGBDBM708223(US12173018, Example 151)
Affinity DataEC50: <3.00E+4nMAssay Description:To establish assay conditions for competition binding, an enzyme titration/saturation binding experiment was initially performed. Bocillin-FL was pre...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
5/5/2025
Entry Details
Go to US Patent

TargetPeptidoglycan D,D-transpeptidase FtsI()
Venatorx Pharmaceuticals

US Patent
LigandPNGBDBM708222(US12173018, Example 150)
Affinity DataEC50: <3.00E+4nMAssay Description:To establish assay conditions for competition binding, an enzyme titration/saturation binding experiment was initially performed. Bocillin-FL was pre...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
5/5/2025
Entry Details
Go to US Patent

TargetPeptidoglycan D,D-transpeptidase FtsI()
Venatorx Pharmaceuticals

US Patent
LigandPNGBDBM708204(US12173018, Example 132)
Affinity DataEC50: <3.00E+4nMAssay Description:To establish assay conditions for competition binding, an enzyme titration/saturation binding experiment was initially performed. Bocillin-FL was pre...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
5/5/2025
Entry Details
Go to US Patent

TargetPeptidoglycan D,D-transpeptidase FtsI()
Venatorx Pharmaceuticals

US Patent
LigandPNGBDBM708210(US12173018, Example 138)
Affinity DataEC50: <3.00E+4nMAssay Description:To establish assay conditions for competition binding, an enzyme titration/saturation binding experiment was initially performed. Bocillin-FL was pre...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
5/5/2025
Entry Details
Go to US Patent

TargetPeptidoglycan D,D-transpeptidase FtsI()
Venatorx Pharmaceuticals

US Patent
LigandPNGBDBM708207(US12173018, Example 135)
Affinity DataEC50: <3.00E+4nMAssay Description:To establish assay conditions for competition binding, an enzyme titration/saturation binding experiment was initially performed. Bocillin-FL was pre...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
5/5/2025
Entry Details
Go to US Patent

TargetPeptidoglycan D,D-transpeptidase FtsI()
Venatorx Pharmaceuticals

US Patent
LigandPNGBDBM708208(US12173018, Example 136)
Affinity DataEC50: <3.00E+4nMAssay Description:To establish assay conditions for competition binding, an enzyme titration/saturation binding experiment was initially performed. Bocillin-FL was pre...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
5/5/2025
Entry Details
Go to US Patent

TargetPeptidoglycan D,D-transpeptidase FtsI()
Venatorx Pharmaceuticals

US Patent
LigandPNGBDBM708206(US12173018, Example 134)
Affinity DataEC50: <3.00E+4nMAssay Description:To establish assay conditions for competition binding, an enzyme titration/saturation binding experiment was initially performed. Bocillin-FL was pre...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
5/5/2025
Entry Details
Go to US Patent

TargetPeptidoglycan D,D-transpeptidase FtsI()
Venatorx Pharmaceuticals

US Patent
LigandPNGBDBM708251(US12173018, Example 180)
Affinity DataEC50: <3.00E+4nMAssay Description:To establish assay conditions for competition binding, an enzyme titration/saturation binding experiment was initially performed. Bocillin-FL was pre...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
5/5/2025
Entry Details
Go to US Patent

TargetPeptidoglycan D,D-transpeptidase FtsI()
Venatorx Pharmaceuticals

US Patent
LigandPNGBDBM708250(US12173018, Example 179)
Affinity DataEC50: <3.00E+4nMAssay Description:To establish assay conditions for competition binding, an enzyme titration/saturation binding experiment was initially performed. Bocillin-FL was pre...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
5/5/2025
Entry Details
Go to US Patent

TargetPeptidoglycan D,D-transpeptidase FtsI()
Venatorx Pharmaceuticals

US Patent
LigandPNGBDBM708122(US12173018, Example 37)
Affinity DataEC50: <3.00E+4nMAssay Description:To establish assay conditions for competition binding, an enzyme titration/saturation binding experiment was initially performed. Bocillin-FL was pre...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
5/5/2025
Entry Details
Go to US Patent

TargetPeptidoglycan D,D-transpeptidase FtsI()
Venatorx Pharmaceuticals

US Patent
LigandPNGBDBM708247(US12173018, Example 176)
Affinity DataEC50: <3.00E+4nMAssay Description:To establish assay conditions for competition binding, an enzyme titration/saturation binding experiment was initially performed. Bocillin-FL was pre...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
5/5/2025
Entry Details
Go to US Patent

TargetPeptidoglycan D,D-transpeptidase FtsI()
Venatorx Pharmaceuticals

US Patent
LigandPNGBDBM708248(US12173018, Example 177)
Affinity DataEC50: <3.00E+4nMAssay Description:To establish assay conditions for competition binding, an enzyme titration/saturation binding experiment was initially performed. Bocillin-FL was pre...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
5/5/2025
Entry Details
Go to US Patent

TargetPeptidoglycan D,D-transpeptidase FtsI()
Venatorx Pharmaceuticals

US Patent
LigandPNGBDBM708260(US12173018, Example 189)
Affinity DataEC50: <3.00E+4nMAssay Description:To establish assay conditions for competition binding, an enzyme titration/saturation binding experiment was initially performed. Bocillin-FL was pre...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
5/5/2025
Entry Details
Go to US Patent

TargetPeptidoglycan D,D-transpeptidase FtsI()
Venatorx Pharmaceuticals

US Patent
LigandPNGBDBM708129(US12173018, Example 45)
Affinity DataEC50: <3.00E+4nMAssay Description:To establish assay conditions for competition binding, an enzyme titration/saturation binding experiment was initially performed. Bocillin-FL was pre...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
5/5/2025
Entry Details
Go to US Patent

TargetPeptidoglycan D,D-transpeptidase FtsI()
Venatorx Pharmaceuticals

US Patent
LigandPNGBDBM708254(US12173018, Example 183)
Affinity DataEC50: <3.00E+4nMAssay Description:To establish assay conditions for competition binding, an enzyme titration/saturation binding experiment was initially performed. Bocillin-FL was pre...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
5/5/2025
Entry Details
Go to US Patent

TargetPeptidoglycan D,D-transpeptidase FtsI()
Venatorx Pharmaceuticals

US Patent
LigandPNGBDBM708235(US12173018, Example 163)
Affinity DataEC50: <3.00E+4nMAssay Description:To establish assay conditions for competition binding, an enzyme titration/saturation binding experiment was initially performed. Bocillin-FL was pre...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
5/5/2025
Entry Details
Go to US Patent

TargetPeptidoglycan D,D-transpeptidase FtsI()
Venatorx Pharmaceuticals

US Patent
LigandPNGBDBM708233(US12173018, Example 161)
Affinity DataEC50: <3.00E+4nMAssay Description:To establish assay conditions for competition binding, an enzyme titration/saturation binding experiment was initially performed. Bocillin-FL was pre...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
5/5/2025
Entry Details
Go to US Patent

TargetPeptidoglycan D,D-transpeptidase FtsI()
Venatorx Pharmaceuticals

US Patent
LigandPNGBDBM708243(US12173018, Example 172)
Affinity DataEC50: <3.00E+4nMAssay Description:To establish assay conditions for competition binding, an enzyme titration/saturation binding experiment was initially performed. Bocillin-FL was pre...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
5/5/2025
Entry Details
Go to US Patent

TargetPeptidoglycan D,D-transpeptidase FtsI()
Venatorx Pharmaceuticals

US Patent
LigandPNGBDBM708239(US12173018, Example 167)
Affinity DataEC50: <3.00E+4nMAssay Description:To establish assay conditions for competition binding, an enzyme titration/saturation binding experiment was initially performed. Bocillin-FL was pre...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
5/5/2025
Entry Details
Go to US Patent

TargetPeptidoglycan D,D-transpeptidase FtsI()
Venatorx Pharmaceuticals

US Patent
LigandPNGBDBM708111(US12173018, Example 22)
Affinity DataEC50: <3.00E+4nMAssay Description:To establish assay conditions for competition binding, an enzyme titration/saturation binding experiment was initially performed. Bocillin-FL was pre...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
5/5/2025
Entry Details
Go to US Patent

TargetPeptidoglycan D,D-transpeptidase FtsI()
Venatorx Pharmaceuticals

US Patent
LigandPNGBDBM708283(US12173018, Example 219)
Affinity DataEC50: <3.00E+4nMAssay Description:To establish assay conditions for competition binding, an enzyme titration/saturation binding experiment was initially performed. Bocillin-FL was pre...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
5/5/2025
Entry Details
Go to US Patent

TargetPeptidoglycan D,D-transpeptidase FtsI()
Venatorx Pharmaceuticals

US Patent
LigandPNGBDBM708155(US12173018, Example 82)
Affinity DataEC50: <3.00E+4nMAssay Description:To establish assay conditions for competition binding, an enzyme titration/saturation binding experiment was initially performed. Bocillin-FL was pre...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
5/5/2025
Entry Details
Go to US Patent

TargetPeptidoglycan D,D-transpeptidase FtsI()
Venatorx Pharmaceuticals

US Patent
LigandPNGBDBM708284(US12173018, Example 220)
Affinity DataEC50: <3.00E+4nMAssay Description:To establish assay conditions for competition binding, an enzyme titration/saturation binding experiment was initially performed. Bocillin-FL was pre...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
5/5/2025
Entry Details
Go to US Patent

TargetPeptidoglycan D,D-transpeptidase FtsI()
Venatorx Pharmaceuticals

US Patent
LigandPNGBDBM708282(US12173018, Example 218)
Affinity DataEC50: <3.00E+4nMAssay Description:To establish assay conditions for competition binding, an enzyme titration/saturation binding experiment was initially performed. Bocillin-FL was pre...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
5/5/2025
Entry Details
Go to US Patent

TargetPeptidoglycan D,D-transpeptidase FtsI()
Venatorx Pharmaceuticals

US Patent
LigandPNGBDBM708280(US12173018, Example 216)
Affinity DataEC50: <3.00E+4nMAssay Description:To establish assay conditions for competition binding, an enzyme titration/saturation binding experiment was initially performed. Bocillin-FL was pre...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
5/5/2025
Entry Details
Go to US Patent

TargetPeptidoglycan D,D-transpeptidase FtsI()
Venatorx Pharmaceuticals

US Patent
LigandPNGBDBM708289(US12173018, Example 225)
Affinity DataEC50: <3.00E+4nMAssay Description:To establish assay conditions for competition binding, an enzyme titration/saturation binding experiment was initially performed. Bocillin-FL was pre...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
5/5/2025
Entry Details
Go to US Patent

TargetPeptidoglycan D,D-transpeptidase FtsI()
Venatorx Pharmaceuticals

US Patent
LigandPNGBDBM708161(US12173018, Example 89)
Affinity DataEC50: <3.00E+4nMAssay Description:To establish assay conditions for competition binding, an enzyme titration/saturation binding experiment was initially performed. Bocillin-FL was pre...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
5/5/2025
Entry Details
Go to US Patent

TargetPeptidoglycan D,D-transpeptidase FtsI()
Venatorx Pharmaceuticals

US Patent
LigandPNGBDBM708162(US12173018, Example 90)
Affinity DataEC50: <3.00E+4nMAssay Description:To establish assay conditions for competition binding, an enzyme titration/saturation binding experiment was initially performed. Bocillin-FL was pre...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
5/5/2025
Entry Details
Go to US Patent

TargetPeptidoglycan D,D-transpeptidase FtsI()
Venatorx Pharmaceuticals

US Patent
LigandPNGBDBM708159(US12173018, Example 87)
Affinity DataEC50: <3.00E+4nMAssay Description:To establish assay conditions for competition binding, an enzyme titration/saturation binding experiment was initially performed. Bocillin-FL was pre...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
5/5/2025
Entry Details
Go to US Patent

TargetPeptidoglycan D,D-transpeptidase FtsI()
Venatorx Pharmaceuticals

US Patent
LigandPNGBDBM708160(US12173018, Example 88)
Affinity DataEC50: <3.00E+4nMAssay Description:To establish assay conditions for competition binding, an enzyme titration/saturation binding experiment was initially performed. Bocillin-FL was pre...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
5/5/2025
Entry Details
Go to US Patent

TargetPeptidoglycan D,D-transpeptidase FtsI()
Venatorx Pharmaceuticals

US Patent
LigandPNGBDBM708268(US12173018, Example 203)
Affinity DataEC50: <3.00E+4nMAssay Description:To establish assay conditions for competition binding, an enzyme titration/saturation binding experiment was initially performed. Bocillin-FL was pre...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
5/5/2025
Entry Details
Go to US Patent

TargetPeptidoglycan D,D-transpeptidase FtsI()
Venatorx Pharmaceuticals

US Patent
LigandPNGBDBM708263(US12173018, Example 192)
Affinity DataEC50: <3.00E+4nMAssay Description:To establish assay conditions for competition binding, an enzyme titration/saturation binding experiment was initially performed. Bocillin-FL was pre...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
5/5/2025
Entry Details
Go to US Patent

TargetPeptidoglycan D,D-transpeptidase FtsI()
Venatorx Pharmaceuticals

US Patent
LigandPNGBDBM708147(US12173018, Example 71)
Affinity DataEC50: <3.00E+4nMAssay Description:To establish assay conditions for competition binding, an enzyme titration/saturation binding experiment was initially performed. Bocillin-FL was pre...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
5/5/2025
Entry Details
Go to US Patent

TargetPeptidoglycan D,D-transpeptidase FtsI()
Venatorx Pharmaceuticals

US Patent
LigandPNGBDBM708276(US12173018, Example 212)
Affinity DataEC50: <3.00E+4nMAssay Description:To establish assay conditions for competition binding, an enzyme titration/saturation binding experiment was initially performed. Bocillin-FL was pre...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
5/5/2025
Entry Details
Go to US Patent

TargetPeptidoglycan D,D-transpeptidase FtsI()
Venatorx Pharmaceuticals

US Patent
LigandPNGBDBM708146(US12173018, Example 70)
Affinity DataEC50: <3.00E+4nMAssay Description:To establish assay conditions for competition binding, an enzyme titration/saturation binding experiment was initially performed. Bocillin-FL was pre...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
5/5/2025
Entry Details
Go to US Patent

TargetPeptidoglycan D,D-transpeptidase FtsI()
Venatorx Pharmaceuticals

US Patent
LigandPNGBDBM708271(US12173018, Example 206)
Affinity DataEC50: <3.00E+4nMAssay Description:To establish assay conditions for competition binding, an enzyme titration/saturation binding experiment was initially performed. Bocillin-FL was pre...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
5/5/2025
Entry Details
Go to US Patent

TargetPeptidoglycan D,D-transpeptidase FtsI()
Venatorx Pharmaceuticals

US Patent
LigandPNGBDBM708272(US12173018, Example 208)
Affinity DataEC50: <3.00E+4nMAssay Description:To establish assay conditions for competition binding, an enzyme titration/saturation binding experiment was initially performed. Bocillin-FL was pre...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
5/5/2025
Entry Details
Go to US Patent

TargetPeptidoglycan D,D-transpeptidase FtsI()
Venatorx Pharmaceuticals

US Patent
LigandPNGBDBM708269(US12173018, Example 204)
Affinity DataEC50: <3.00E+4nMAssay Description:To establish assay conditions for competition binding, an enzyme titration/saturation binding experiment was initially performed. Bocillin-FL was pre...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
5/5/2025
Entry Details
Go to US Patent

Displayed 1 to 50 (of 212 total ) | Next | Last >>
Jump to: